Status:
COMPLETED
A Study to Evaluate the Safety and Tolerability of MK0217 in Women (0217-219)
Lead Sponsor:
Organon and Co
Conditions:
Postmenopausal Osteoporosis
Eligibility:
FEMALE
25+ years
Phase:
PHASE3
Brief Summary
This study is to assess the safety and tolerability of MK0217 being evaluated to treat women with postmenopausal osteoporosis.
Eligibility Criteria
Inclusion
- Women with postmenopausal osteoporosis
Exclusion
- High risk for fractures
- Esophageal abnormalities
- Upper gastrointestinal symptoms that are not relieved with medication
- Metabolic bone disease (example - vitamin D deficiency)
- Medications that would affect the breakdown or build-up of bone
Key Trial Info
Start Date :
March 19 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2004
Estimated Enrollment :
454 Patients enrolled
Trial Details
Trial ID
NCT00092027
Start Date
March 19 2003
End Date
March 15 2004
Last Update
August 14 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.